Adipsic diabetes insipidus.
Kothari V, Cardona Z, Eisenberg Y.
Handb Clin Neurol. 2021;181:261-273. doi: 10.1016/B978-0-12-820683-6.00019-1.
Evaluation and treatment of hypernatremia: a practical guide for physicians.
Liamis G, Filippatos TD, Elisaf MS.
Postgrad Med. 2016;128(3):299-306. doi: 10.1080/00325481.2016.1147322. Epub 2016 Feb 23.
Copeptin and its role in the diagnosis of diabetes insipidus and the syndrome of inappropriate antidiuresis.
Refardt J, Winzeler B, Christ-Crain M.
Clin Endocrinol (Oxf). 2019 Jul;91(1):22-32. doi: 10.1111/cen.13991. Epub 2019 May 8.
Ongoing peer-review issues.
Sutherland T.
Intern Med J. 2020 May;50(5):646. doi: 10.1111/imj.14832.
Hyponatremia and hypernatremia.
Fried LF, Palevsky PM.
Med Clin North Am. 1997 May;81(3):585-609. doi: 10.1016/s0025-7125(05)70535-6.
Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case-control study with nested, randomised, double-blind, placebo-controlled crossover trial.
Atila C, Holze F, Murugesu R, Rommers N, Hutter N, Varghese N, Sailer CO, Eckert A, Heinrichs M, Liechti ME, Christ-Crain M.
Lancet Diabetes Endocrinol. 2023 Jul;11(7):454-464. doi: 10.1016/S2213-8587(23)00120-1. Epub 2023 May 13.
[Hormonal dysnatremia].
Karaca P, Desailloud R.
Ann Endocrinol (Paris). 2013 Oct;74 Suppl 1:S42-51. doi: 10.1016/S0003-4266(13)70020-9.
Vasopressin and Copeptin in health and disease.
Christ-Crain M.
Rev Endocr Metab Disord. 2019 Sep;20(3):283-294. doi: 10.1007/s11154-019-09509-9.
Concomitant neuroleptic malignant syndrome and diabetes insipidus.
Zaki C, Ugell M, Vo T, Liu S.
JAAPA. 2022 Aug 1;35(8):31-33. doi: 10.1097/01.JAA.0000840488.74228.46.
[Optic neuropathy in diabetic subjects].
Algan M, Ziegler O, Drouin P.
Diabete Metab. 1993 Sep-Oct;19(5):395-9.
